文献速递炎症性肠病

炎症性肠病疾病严重程度指数与心理症状及生活质量相关,并可预测更复杂的疾病病程

The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course.
PubMed 文献 · Aliment Pharmacol Ther · 2022-05-27

研究前瞻性随访172例炎症性肠病(IBD)患者12个月,评估基线疾病严重程度指数(DSI)与心理症状、生活质量及疾病结局的关联。DSI在应激、抑郁、焦虑及生活质量受损患者中显著更高,仅基线DSI(OR 1.05)和内镜下活动性疾病(OR 6.12)与复杂IBD病程相关,DSI>23强烈预测复杂病程(OR 8.31)。

要点

  • DSI在合并中度至重度应激、抑郁、焦虑及生活质量受损的IBD患者中显著更高
  • 仅基线DSI(OR 1.05)和内镜下活动性疾病(OR 6.12)与12个月复杂IBD病程相关
  • DSI>23强烈预测复杂IBD病程(OR 8.31,p<0.001)

核心结论

  • DSI与IBD患者的心理困扰和生活质量受损相关,并可预测更复杂的疾病病程。

研究设计与样本

  • 前瞻性队列研究,纳入接受回结肠镜检查的IBD患者172例(克罗恩病100例,女性91例),随访12个月。
  • 基线评估DSI、心理症状(感知应激PSS-10、抑郁PHQ-9、焦虑GAD-7)和生活质量(IBDQ-32)评分。
  • 采用逻辑回归识别预测12个月复杂IBD病程的变量,复杂病程为需升级生物制剂/免疫调节剂治疗疾病复发、反复使用皮质类固醇、IBD相关住院和手术的复合结局。
  • 采用受试者工作特征(ROC)分析确定预测复杂病程的最佳DSI阈值,多变量逻辑回归评估达到该结局的风险。

主要发现

  • 基线DSI中位数为21(IQR 11-32),97例患者基线时存在内镜下活动性疾病。
  • DSI在合并中度至重度应激症状(PSS-10>14,p<0.01)、抑郁(PHQ-9≥10,p<0.01)、焦虑(GAD-7≥10,p<0.05)及生活质量受损(IBDQ-32<168,p<0.01)的患者中显著更高。
  • 仅基线DSI(OR 1.05,p<0.01)和内镜下活动性疾病(OR 6.12,p<0.01)与复杂IBD病程相关。
  • DSI>23强烈预测复杂IBD病程(OR 8.31,p<0.001)。

关键数值与推荐

  • 复杂IBD病程的复合结局包括:需升级生物制剂/免疫调节剂治疗疾病复发、反复使用皮质类固醇、IBD相关住院和手术。
  • DSI>23为预测复杂IBD病程的最佳阈值,OR 8.31(p<0.001)。
  • 内镜下活动性疾病与复杂IBD病程相关,OR 6.12(p<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Disease Severity Index (DSI) is a novel tool to predict disease severity in inflammatory bowel disease (IBD). However, its ability to predict disease complications and the presence of psychosocial comorbidity is unclear. AIMS: To assess prospectively associations between the DSI and psychological symptoms, quality-of-life (QoL) and disease outcomes in an IBD cohort. METHODS: Patients with IBD undergoing ileocolonoscopy were followed prospectively for 12 months. DSI, psychological symptoms (perceived stress (PSS-10), depression (PHQ-9), anxiety (GAD-7)) and QoL (IBDQ-32) scores were assessed at baseline. Logistic regression identified variables predicting a complicated IBD course at 12 months (composite outcome of need for escalation of biological/immunomodulator for disease relapse, recurrent corticosteroid use, IBD-related hospitalisation and surgery). Receiver operating characteristics (ROC) analysis identified optimal DSI thresholds predicting a complicated disease course and multivariable logistic regression assessed the risk of reaching this outcome. RESULTS: One hundred and seventy-two patients were recruited (100 Crohn's disease, 91 female). Median DSI was 21 (IQR 11-32) and 97 patients had endoscopically active disease at baseline. The DSI was significantly higher in patients with symptoms of moderate-severe stress (PSS-10 > 14, p < 0.01), depression (PHQ-9 ≥ 10, p < 0.01), anxiety (GAD-7 ≥ 10, p < 0.05) and impaired quality-of-life (IBDQ-32 < 168, p < 0.01). Only the baseline DSI (OR 1.05, p < 0.01) and endoscopically active disease (OR 6.12, p < 0.01) were associated with a complicated IBD course. A DSI > 23 was strongly predictive of a complicated IBD course (OR 8.31, p < 0.001). CONCLUSIONS: The DSI is associated with psychological distress, impaired QoL and predicts a more complicated disease course in patients with IBD.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Swaminathan A, Fan D, Borichevsky GM, et al. The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. Aliment Pharmacol Ther. 2022. PMID: 35633043. doi:10.1111/apt.17058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。